Publications › Privalsky

Privalsky

Alternative mRNA Splicing of Corepressors Generates Variants That Play Opposing Roles in Adipocyte Differentiation.
Goodson ML, Mengeling BJ, Jonas BA, Privalsky ML.
Journal of Biological Chemistry, 2011 Dec 30; 286(52):44988-99. doi:10.1074/jbc.M111.291625
PMID:22065574 PMCID:PMC3247966


Mutant Thyroid Hormone Receptors (TRs) Isolated from Distinct Cancer Types Display Distinct Target Gene Specificities: A Unique Regulatory Repertoire Associated with Two Renal Clear Cell Carcinomas.
Rosen MD, Chan IH, Privalsky ML.
Molecular Endocrinology, 2011 Aug; 25(8):1311-25. doi:10.1210/me.2010-0420
PMID:21622534 PMCID:PMC3146248


A Mechanism for Pituitary-Resistance to Thyroid Hormone (PRTH) Syndrome: a Loss in Cooperative Coactivator Contacts by Thyroid Hormone Receptor (TR)β2.
Lee S, Young BM, Wan W, Chan IH, Privalsky ML.
Molecular Endocrinology. 2011 Jul;25(7):1111-25. doi: 10.1210/me.2010-0448.
PMID:21622532 PMCID:PMC3125096


NCoR1 regulates thyroid hormone receptor isoform-dependent adipogenesis.
Zhu XG, Kim DW, Goodson ML, Privalsky ML, Cheng SY.
Journal of Molecular Endocrinology, 2011 Jun 9; 46(3):233-44. doi:10.1530/JME-10-0163
PMID:21389087 PMCID:PMC3457783


Thyroid Hormone Receptor Mutations in Cancer and Resistance to Thyroid Hormone: Perspective and Prognosis.
Rosen MD, Privalsky ML.
Journal of Thyroid Research, 2011; 2011:361304. doi:10.4061/2011/361304
PMID:21760978 PMCID:PMC3134260


Aberrant Corepressor Interactions Implicated in PML-RARα and PLZF-RARα Leukemogenesis Reflect an Altered Recruitment and Release of Specific NCoR and SMRT Splice Variants.
Mengeling BJ, Phan TQ, Goodson ML, Privalsky ML.
Journal of Biological Chemistry, 2011 Feb 11; 286(6):4236-47. doi:10.1074/jbc.M110.200964
PMID:21131350 PMCID:PMC3039402


Regulation of SMRT corepressor dimerization and composition by MAP kinase phosphorylation.
Varlakhanova N, Hahm JB, Privalsky ML.
Molecular and Cellular Endocrinology, 2011 Jan 30; 332(1-2):180-8. doi:10.1016/j.mce.2010.10.010
PMID:20965228 PMCID:PMC3011023


Nuclear receptor coregulators as a new paradigm for therapeutic targeting.
Hsia EY, Goodson ML, Zou JX, Privalsky ML, Chen HW.
Advanced Drug Delivery Reviews, 2010 Oct 30; 62(13):1227-37. doi:10.1016/j.addr.2010.09.016
PMID:20933027